Medtronic CFO awarded stock, options and PSUs
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medtronic EVP & Chief Financial Officer Thierry Pieton reported equity awards dated August 3, 2026, including 11,537 restricted ordinary shares, 28,842 performance share units tied to three-year performance goals, and 81,945 stock options with an $86.68 exercise price expiring in 2036.
Insider Trade Summary
Grant/Award: 122,324 shares
Grant/Award
3 txns
Insider
Pieton Thierry
Role
EVP & Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Share Units F3, F4, F5 | 28,842 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F6 | 81,945 | $0.00 | $0.00 |
| Grant/Award | Ordinary Shares F1, F2 | 11,537 | $0.00 | $0.00 |
Holdings After Transaction:
Performance Share Units — 28,842 contracts (Direct);
Stock Option (Right to Buy) — 81,945 contracts (Direct);
Ordinary Shares — 49,645 shares (Direct)
Footnotes (6)
- F1. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- F2. Includes 534 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- F3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- F4. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
- F5. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 28,842 shares will be issued. If maximum performance metrics are achieved, 69,221 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F6. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Key Figures
Restricted shares granted: 11,537 shares
Shares owned after grant: 49,645 shares
PSU target share amount: 28,842 shares
+4 more
7 metrics
Restricted shares granted
11,537 shares
Ordinary Shares granted as restricted stock units on 2026-08-03
Shares owned after grant
49,645 shares
Direct Medtronic ordinary share holdings after 2026-08-03 transaction
PSU target share amount
28,842 shares
Target shares issuable if PSU performance metrics are achieved
PSU maximum share amount
69,221 shares
Maximum shares issuable if PSU performance metrics are fully achieved
Stock options granted
81,945 options
Stock Option (Right to Buy) grant on 2026-08-03
Option exercise price
$86.68 per share
Exercise price for 81,945 stock options expiring 2036-08-03
Option expiration date
2036-08-03
Expiration date for stock options granted to the CFO
Key Terms
restricted stock units, performance share units, dividend reinvestment, Stock Option (Right to Buy)
4 terms
restricted stock units financial
"Represents restricted stock units that vest 100% on the third anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
dividend reinvestment financial
"Includes 534 shares acquired through dividend reinvestment since the last report"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) reported as a derivative security grant"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Medtronic (MDT) CFO Thierry Pieton report on this Form 4?
Thierry Pieton reported 11,537 restricted ordinary shares, 28,842 performance share units at target, and 81,945 stock options with an $86.68 exercise price, all granted as equity compensation on August 3, 2026.
What are the terms of Thierry Pieton’s new Medtronic (MDT) stock options?
Pieton received 81,945 stock options with an exercise price of $86.68 per share, expiring on August 3, 2036. These options vest at 25% per year starting on the first anniversary of the grant.
When will Thierry Pieton’s Medtronic (MDT) restricted stock units vest?
The restricted stock units represented by the 11,537 ordinary shares vest 100% on the third anniversary of the grant date, providing a time-based vesting schedule linked to continued service.
What performance period applies to Thierry Pieton’s new Medtronic (MDT) PSUs?
The performance share units use a three-year performance period. Certain performance conditions are scheduled to be assessed by April 27, 2029, determining how many shares, if any, will ultimately be issued.
AI-generated analysis. How Rhea-AI works. Not financial advice.
